Author:
Yu Allen T.,Hanna David N.,Li Thomas M.,Sarfaty Elad,Khajoueinejad Nazanin,Li Judy,Golas Benjamin,Hiotis Spiros,Labow Daniel,Sarpel Umut,Magge Deepa R.,Cohen Noah A.
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Tseng J, Bryan DS, Poli E, Sharma M, Polite BN, Turaga KK. Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer. Lancet Oncol. 2017;18(6):711–2.
2. Sugarbaker PH, Landy D, Pascal R. Intraperitoneal chemotherapy for peritoneal carcinomatosis from colonic or appendiceal cystadenocarcinoma: rationale and results of treatment. Prog Clin Biol Res. 1990;354B:141–70.
3. Sarfaty E, Khajoueinejad N, Yu AT, Hiotis S, Golas BJ, Sarpel U, et al. Actual 5-year survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2024;31(3):1970–9.
4. Sugarbaker PH. Management of peritoneal carcinomatosis. Acta Med Austriaca. 1989;16(3–4):57–60.
5. Morris VK, Kennedy EB, Baxter NN, Benson AB 3rd, Cercek A, Cho M, et al. Treatment of metastatic colorectal cancer: ASCO guideline. J Clin Oncol. 2023;41(3):678–700.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献